JILLIAN DICKENSKI: Open Payments
NPI 1700580438 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,161 in 61 payments from 20 companies in 2025. Trend: 2023 $31 · 2024 $890 · 2025 $1,161
Food & beverage: $1,161
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $174 |
| Novo Nordisk Inc | 7 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $123 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| ABBVIE INC. | 4 | $76 |
| Teva Pharmaceuticals USA, Inc. | 4 | $69 |
| Lilly USA, LLC | 3 | $56 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
Products named: Kerendia, JARDIANCE, NURTEC ODT, VYNDAQEL, AUSTEDO XR, Auvelity, CAPLYTA, FARXIGA.
Industry payments across MD — which companies pay providers there.
